Vilmorin & Cie - Annual report 2017-2018

Financial INFORMATION 5 ANNUAL REPORT Vilmorin & Cie 180 2017-2018 3- Financial information of the main equity shares 3.1 - For fiscal year 2017-2018 In millions of euros Bio Seeds  (1) DLF France  (2) Unisigma Genoplante- Valor (1) Australian Grain Technology (AGT) (3) AgReliant Genetics Inc. AgReliant Genetics LLC Genective Sales 23.1 24.9 2.7 0.4 29.8 35.0 487.0 - Net income 3.0 0.3 -0.1 0.1 10.8 2.2 22.4 0.1 Assets 21.7 8.7 2.1 4.0 75.7 39.6 518.7 13.8 Liabilities (excluding equity) 4.8 3.4 1.6 0.1 21.8 29.3 307.6 5.5 In millions of euros GIE Semences de Brie Soltis Seed Co Zimbabwe (4) Canterra Seeds (3) Hengji Limagrain Carthage Génétique (5) Prime Seed Co Botswana (4) Prime Seed Co Zimbabwe (4) Sales 1.1 18.5 53.1 20.0 6.5 0.5 0.6 4.8 Net income -0.5 3.5 18.0 0.3 -2.2 0.1 - -0.2 Assets 1.3 41.5 213.7 15.2 21.9 1.0 2.9 6.2 Liabilities (excluding equity) 1.4 17.8 52.2 5.8 14.2 0.3 1.0 3.8 (1) Accounts closed on December 31, 2017 (2) Accounts closed on June 30, 2018 (3) Accounts closed on September 30, 2017 (4) Accounts closed on March 31, 2018 (5) Interim close on June 30, 2018 3.2 - For fiscal year 2016-2017 In millions of euros Bio Seeds  (1) DLF France  (2) Unisigma Genoplante- Valor (1) Australian Grain Technology (AGT) (3) AgReliant Genetics Inc. AgReliant Genetics LLC Sales 19.0 23.1 2.9 0.5 25.1 34.8 569.3 Net income 0.6 0.2 0.1 0.1 7.4 1.4 43.1 Assets 18.1 8.3 2.3 4.0 61.3 34.7 500.6 Liabilities (excluding equity) 4.3 3.1 1.6 0.2 15.4 25.8 285.7 In millions of euros Genective GIE Semences de Brie Soltis Seed Co (4) Canterra Seeds (3) Hengji Limagrain Carthage Génétique (5) Sales - 1.2 18.1 123.5 23.4 3.0 0.4 Net income 0.2 - 3.7 19.0 0.7 -3.0 0.2 Assets 10.6 1.8 40.2 204.8 14.0 20.5 0.8 Liabilities (excluding equity) 8.5 1.5 17.7 61.2 4.4 10.7 0.2 (1) Accounts closed on December 31, 2016 (2) Accounts closed on June 30, 2016 (3) Accounts closed on September 30, 2016 (4) Accounts closed on March 31, 2017 (5) Interim close on June 30, 2017 5.1. Consolidated Financial Statements

RkJQdWJsaXNoZXIy NjQyNDQw